Ascendis Pharma A/S - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ASND Nasdaq 2836 ascendispharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ascendis Pharma A/S

Ascendis Pharma A/S (ASND): A Bull Case Theory - Jan 15th, 2026 11:03 am
Ascendis Pharma (ASND) Surges 3.0%: Is This an Indication of Further Gains? - Jan 14th, 2026 4:14 am
Is Ascendis Pharma (ASND) Pricing Reflect Its DCF Versus Pipeline Progress And Regulatory Updates - Jan 13th, 2026 3:08 pm
Ascendis Pharma A/S Touts €683M Product Revenue, Feb PDUFA Catalyst at JPM Healthcare Conference - Jan 12th, 2026 5:02 pm
What Ascendis Pharma (ASND)'s Phase 2 COACH Combo Data Means For Shareholders - Jan 12th, 2026 4:10 pm
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - Jan 12th, 2026 9:19 am
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference - Jan 9th, 2026 4:01 pm
Ascendis Pharma COACH Week 52 data show combo TransCon CNP + hGH boosts growth in achondroplasia - Jan 8th, 2026 9:03 pm
Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH) - Jan 8th, 2026 2:01 pm
Assessing Ascendis Pharma (ASND) Valuation After Strong Multi Year Returns And Pipeline Progress - Jan 8th, 2026 9:13 am
Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Jan 5th, 2026 6:30 am
European Equities Traded in the US as American Depositary Receipts Little Changed in Friday Trading; Gains 2% for Week - Dec 26th, 2025 9:07 am
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Dec 24th, 2025 9:14 am
Assessing Ascendis Pharma’s 2025 Valuation After Big Run and DCF Upside Potential - Dec 21st, 2025 12:06 pm
European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading - Dec 18th, 2025 9:05 am
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading - Dec 16th, 2025 9:02 am
Liberty All-Star® Growth Fund, Inc. November 2025 Monthly Update - Dec 15th, 2025 1:01 pm
Ford Upgraded, Amazon Downgraded: Updated Rankings on Top Blue-Chip Stocks - Dec 15th, 2025 7:42 am
Assessing Ascendis Pharma (ASND)’s Valuation After a Strong 69.72% One-Year Shareholder Return - Dec 14th, 2025 10:06 pm
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Shares Still Up This Week - Dec 12th, 2025 9:17 am